Epigenomic analysis sheds light on risk factors for ALS

In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.

Related Keywords

United States ,American ,Lyle Ostrow ,Ernest Fraenkel ,Stanislav Tsitkov ,Abbvie Foundation ,Bruce Edwards Foundation ,National Institutes Of Health ,Groverm Hermann Professor In Health Sciences ,Nature Communications ,Bari Lipp Foundation ,Microsoft ,Caterpillar Foundation ,Team Gleason ,Robert Packard Center ,National Football League ,Muscular Dystrophy Association ,A Cure Foundation ,Fishman Family Foundation ,American Airlines ,Jean Pape Adams Charitable Foundation ,Drug Administration ,Research At Johns Hopkins University ,Chan Zuckerberg Initiative ,Department Of Biological Engineering ,Us National Institutes Of Health ,Health Sciences ,Biological Engineering ,Lewis Katz School ,Temple University ,Johns Hopkins University ,Travelers Insurance ,Cure Foundation ,Stay Strong ,Aviators Against ,Myles Turner ,Gates Ventures ,Bari Lipp ,National Institutes ,Research Fellowship Program ,Drug Discovery ,Amyotrophic Lateral Sclerosis Als ,Epigenomics ,Induced Pluripotent Stem Cells ,